Within the MCI cohorts, a higher baseline of Cer C22:0 and Cer C24:0 in blood could predict hippocampal volume loss and cognitive impairment over the course of 1 year,131 thus making it a potential early indicator of AD progression. Here, CBLN1 is linked to Cognitive impairment.